Financial Data and Key Metrics Changes - Aflac reported Q4 2025 net earnings per diluted share of $2.64 and adjusted earnings per diluted share of $1.57, with full-year net earnings per diluted share at $6.82 and adjusted earnings at $7.49 [5] - Adjusted earnings per diluted share increased 0.6% year-over-year for Q4 2025, while adjusted book value per share rose 0.5% [14] - The adjusted return on equity (ROE) was 11.7%, and 14.5% excluding foreign currency remeasurement [14] Business Line Data and Key Metrics Changes - Aflac Japan's sales increased by 15.7% in Q4 and 16% for the full year 2025, driven by the launch of the Moraito cancer insurance product [6][7] - Aflac U.S. generated nearly $1.6 billion in new sales for 2025, with over one-third coming from Q4 [8] - Premium persistency in Aflac Japan remained strong at 93.1%, while Aflac U.S. reported a persistency of 79.2% [9][10] Market Data and Key Metrics Changes - Aflac Japan's net earned premiums in yen terms declined by 1.9% for Q4 2025, while underlying earned premiums decreased by 1.2% [14][15] - In the U.S., net earned premiums increased by 4%, but the total benefit ratio rose to 48.6%, driven by higher claims activity [17] Company Strategy and Development Direction - Aflac continues to emphasize third sector protection and has introduced innovative products to meet changing customer needs [7][8] - The company aims to maintain strong premium persistency while offsetting the impact of reinsurance and policies reaching paid-up status [7] - Aflac plans to enhance its capital deployment strategy, including a 5.2% increase in dividends for Q1 2026 and a record $3.5 billion in share repurchases for 2025 [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's financial strength and ability to navigate increasing out-of-pocket medical expenses faced by consumers [10] - The outlook for 2026 includes expectations for underlying earned premiums in Japan to decline by 1%-2% and net earned premium growth in the U.S. to be in the lower end of the 3%-6% range [25] Other Important Information - Aflac's capital position remains strong, with an SMR above 970% and an estimated regulatory ESR of 253% [22][23] - The company has enhanced liquidity and capital flexibility by creating off-balance sheet pre-capitalized trusts [21] Q&A Session Summary Question: Concerns about surrender levels in Japan due to rising yields - Management acknowledged the potential for increased surrenders but noted that they have not yet experienced significant changes [30] Question: Impact of ESR on M&A or capital deployment - Management confirmed that while capital is available for M&A, finding suitable operational and strategic targets remains challenging [33] Question: Lower benefit ratio guidance in Japan - Management explained that the lower benefit ratio is influenced by updated actuarial assumptions and new product introductions [36][38] Question: Group versus non-group sales performance - Management reported strong growth in group sales, particularly in network dental and vision products, while traditional voluntary benefits have been flat [72] Question: Future premium growth in Japan - Management indicated that strong persistency is limiting premium growth, with expectations for a positive turn in the future [78]

Aflac (NYSE:AFL) Q4 2025 Earnings call February 05, 2026 08:00 AM ET Speaker8Good morning, everyone, and welcome to the Aflac Incorporated Fourth Quarter 2025 Earnings Conference Call. All participants will be in a listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press Star and then one on your touchtone phone. To withdraw your qu ...

分组1 - Aflac reported quarterly earnings of $1.57 per share, missing the Zacks Consensus Estimate of $1.71 per share, representing an earnings surprise of -8.10% [1] - The company posted revenues of $4.87 billion for the quarter, surpassing the Zacks Consensus Estimate by 8.70%, compared to year-ago revenues of $4.31 billion [2] - Aflac has surpassed consensus EPS estimates two times over the last four quarters and topped consensus revenue estimates three times during the same period [2] 分组2 - The current consensus EPS estimate for the coming quarter is $1.79 on revenues of $4.44 billion, and for the current fiscal year, it is $7.36 on revenues of $17.55 billion [7] - The Zacks Industry Rank for Insurance - Accident and Health is currently in the bottom 30% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8] - Aflac shares have added about 1.6% since the beginning of the year, outperforming the S&P 500's gain of 1.1% [3]

Financial Data and Key Metrics Changes - Adjusted earnings per diluted share increased 0.6% year-over-year to $1.57, excluding the effect of foreign currency [1] - Adjusted book value per share increased 0.5%, with an adjusted ROE of 11.7% and 14.5% excluding foreign currency remeasurement [1] - Overall results for the quarter were viewed as solid [1] Business Line Data and Key Metrics Changes - In Japan, net earned premiums in yen terms declined 1.9%, while underlying earned premiums decreased 1.2% [2] - Japan's total benefit ratio improved to 65%, down 150 basis points year-over-year, with reserve remeasurement gains favorably impacting the ratio [2] - In the U.S., net earned premiums increased by 4%, but premium persistency declined slightly by 10 basis points to 79.2% [4] - The total benefit ratio in the U.S. was 48.6%, up 230 basis points year-over-year, driven by higher claims activity [4] Market Data and Key Metrics Changes - Japan's expense ratio was 22%, up 120 basis points year-over-year, primarily due to sales promotion expenses [3] - U.S. expense ratio was 40.4%, up 10 basis points year-over-year, influenced by timing of spend from previous quarters [4] - Adjusted net investment income in Japan was down 3.9%, while in the U.S. it decreased by 2.8% [3][5] Company Strategy and Development Direction - The company plans to continue focusing on growth initiatives in group life and disability, network dental and vision, and direct-to-consumer segments [4] - For 2026, the company expects underlying earned premiums in Japan to decline by 1%-2% and anticipates a benefit ratio in the 60%-63% range [11][12] - In the U.S., net earned premium growth is expected to be in the lower end of the 3%-6% range, with a benefit ratio forecasted between 48%-52% [12] Management's Comments on Operating Environment and Future Outlook - Management expressed satisfaction with the performance of the investment portfolio, noting no charge-offs for the commercial real estate portfolio [6] - The company has improved its liquidity and capital flexibility, lowering the minimum liquidity balance at the holding company [9] - Capital ratios remain strong, with an estimated combined RBC of 575% and an SMR above 970% [10] Other Important Information - The company repurchased $800 million of its own stock and paid dividends of $303 million in Q4, indicating strong capital management [11] - Adjusted leverage was 21.4%, within the target range of 20%-25%, influenced by currency exchange rates [9] Q&A Session Summary Question: What is the outlook for Aflac Japan's earned premiums? - The company expects underlying earned premiums in Japan to decline by 1%-2% in 2026 [11] Question: How does the company view its expense ratios moving forward? - The expense ratio in Japan is expected to be in the 20%-23% range, while the U.S. expense ratio is anticipated to be in the 36%-39% range [12]

Financial Data and Key Metrics Changes - Adjusted earnings per diluted share increased 0.6% year-over-year to $1.57, excluding foreign currency effects [1] - Adjusted book value per share increased 0.5%, with an adjusted ROE of 11.7% and 14.5% excluding foreign currency remeasurement [1] - Overall results for the quarter were viewed as solid [1] Business Line Data and Key Metrics Changes - In Japan, net earned premiums in yen terms declined 1.9%, while underlying earned premiums decreased 1.2% [2] - Japan's total benefit ratio improved to 65%, down 150 basis points year-over-year, with reserve remeasurement gains favorably impacting the ratio by approximately 110 basis points [2] - In the U.S., net earned premiums increased by 4%, but premium persistency declined slightly by 10 basis points to 79.2% [4] - The total benefit ratio in the U.S. was 48.6%, up 230 basis points year-over-year, driven by higher claims activity [4] Market Data and Key Metrics Changes - Japan's expense ratio was 22%, up 120 basis points year-over-year, primarily due to sales promotion expenses [3] - U.S. expense ratio was 40.4%, up 10 basis points year-over-year, influenced by timing of spend from previous quarters [4] - Adjusted net investment income in Japan decreased by 3.9%, while in the U.S. it was down 2.8% [3][5] Company Strategy and Development Direction - The company plans to continue managing its balance sheet flexibly and tactically to drive strong risk-adjusted ROE [11] - For 2026, the company expects underlying earned premiums in Japan to decline by 1%-2% and the expense ratio to be in the 20%-23% range [12] - In the U.S., net earned premium growth is expected to be at the lower end of the 3%-6% range, with a benefit ratio forecasted between 48%-52% [12] Management's Comments on Operating Environment and Future Outlook - Management expressed satisfaction with the performance of the investment portfolio, noting no charge-offs for the commercial real estate portfolio [6] - The company has improved its liquidity and capital flexibility, lowering the minimum liquidity balance at the holding company [8] - The capital position remains strong, with an SMR above 970% and an estimated regulatory ESR of 253% [9][10] Other Important Information - The company repurchased $800 million of its own stock and paid dividends of $303 million in Q4 [11] - Adjusted leverage was 21.4%, within the target range of 20%-25% [9] - The company recorded a pre-tax adjusted loss of $31 million in Corporate and Other [5] Q&A Session Summary Question: What is the outlook for Aflac Japan's earned premiums in 2026? - The company expects underlying earned premiums to decline by 1%-2% in 2026 [12] Question: How does the company plan to manage its expense ratios moving forward? - The company anticipates the expense ratio in Japan to be in the 20%-23% range and in the U.S. to be between 36%-39% as new business lines scale [12]

FINAL 02/04/2026 Financial Supplement Fourth Quarter 2025 This document is a statistical supplement to Aflac's quarterly earnings release. Throughout the presentation, amounts presented may not foot due to rounding. As you review the supplement, please note the non-U.S. GAAP financial measures and definitions found at the back of this document. The Company adopted the Financial Accounting Standards Board's Accounting Standard Update 2018-12 Financial Services - Insurance: Targeted Improvements to the Accoun ...

Core Insights - Aflac Incorporated reported a decline in total revenues and net earnings for the fourth quarter and full year of 2025 compared to 2024, indicating challenges in financial performance [1][5][18]. Financial Performance - Total revenues for Q4 2025 were $4.9 billion, down from $5.4 billion in Q4 2024, representing a decrease of 9.9% [1][25]. - Net earnings for Q4 2025 were $1.4 billion, or $2.64 per diluted share, compared to $1.9 billion, or $3.42 per diluted share in Q4 2024, reflecting a decline of 27.5% [1][26]. - For the full year 2025, total revenues decreased by 9.3% to $17.2 billion from $18.9 billion in 2024 [5][25]. - Net earnings for the full year 2025 were $3.6 billion, or $6.82 per diluted share, down from $5.4 billion, or $9.63 per diluted share in 2024, marking a 33.0% decline [5][26]. Investment Gains - Q4 2025 net investment gains were $537 million, or $1.03 per diluted share, compared to $1.0 billion, or $1.86 per diluted share in Q4 2024 [2][32]. - The investment gains were influenced by net gains on derivatives and foreign currency activities, alongside losses from sales and redemptions [2]. Adjusted Earnings - Adjusted earnings for Q4 2025 were $818 million, down 5.4% from $865 million in Q4 2024 [3][32]. - Adjusted earnings per diluted share increased by 0.6% to $1.57 in Q4 2025 [3][32]. - For the full year 2025, adjusted earnings were $4.0 billion, or $7.49 per diluted share, compared to $4.1 billion, or $7.21 per diluted share in 2024, reflecting a slight decrease of 1.6% [5][34]. Shareholders' Equity - Shareholders' equity at the end of Q4 2025 was $29.5 billion, or $56.85 per share, up from $26.1 billion, or $47.45 per share at the end of Q4 2024 [4][37]. - The increase in shareholders' equity was attributed to changes in discount rate assumptions on insurance reserves [4]. Aflac Japan Performance - In yen terms, Aflac Japan's net earned premiums for Q4 2025 were ¥252.6 billion, a decrease of 1.9% year-over-year [7][8]. - Adjusted net investment income in yen decreased by 3.9% to ¥97.4 billion [7]. - For the full year, net earned premiums in yen were ¥1.0 trillion, down 3.9% from the previous year [8]. Aflac U.S. Performance - Aflac U.S. net earned premiums increased by 4.0% to $1.5 billion in Q4 2025, reflecting improved sales [12][13]. - Total adjusted revenues for Aflac U.S. were up 3.3% to $1.7 billion in Q4 2025 [12]. - For the full year, net earned premiums increased by 2.9% to $6.0 billion [13]. Capital Management - The board declared a first-quarter dividend of $0.61 per share, payable on March 2, 2026 [17]. - Aflac repurchased $800 million worth of shares in Q4 2025, with a total of $3.5 billion in share repurchases for the year [17][22].

Senior Executive Vice President CFO, Aflac Incorporated Fourth Quarter 2025 Update Max K. Brodén Forward-Looking Information and Non-U.S. GAAP Financial Measures The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" to encourage companies to provide prospective information, so long as those informational statements are identified as forward-looking and are accompanied by meaningful cautionary statements identifying important factors that could cause actual results to differ materiall ...

Core Insights - Aflac Incorporated will have President Virgil R. Miller participate in a fireside chat at the UBS Financial Services Conference on February 11, 2026, at 9:40 a.m. ET, which will be webcast live [1] Company Overview - Aflac Incorporated is a Fortune 500 company that has provided financial protection for over 70 years to millions of policyholders through its subsidiaries in the U.S. and Japan [2] - In the U.S., Aflac is the leading provider of supplemental health insurance products, while in Japan, Aflac Life Insurance Japan is the top provider of cancer and medical insurance based on policies in force [2] - The company has been recognized as one of the World's Most Ethical Companies for 19 consecutive years and has been included in Fortune's World's Most Admired Companies for 24 years [2] - Aflac became a signatory of the Principles for Responsible Investment in 2021 and has been part of the Dow Jones Sustainability North America Index for 11 years [2] Event Information - A replay of the presentation will be available within 24 hours after the live event [2]

Group 1: Company Overview - Aflac Incorporated (NYSE:AFL) provides supplemental insurance and financial protection products primarily in the United States and Japan [3]. Group 2: Price Target Adjustment - TD Cowen has reduced its price target for Aflac from $102 to $100 while maintaining a Hold rating, citing modest headwinds from lower returns on alternative investments [1]. Group 3: Cybersecurity Incident - Aflac experienced a significant cybersecurity breach, with hackers accessing customer data affecting approximately 22.65 million individuals [2]. - The stolen data included sensitive information such as names, dates of birth, home addresses, Social Security numbers, and health insurance details [3]. - Aflac is notifying affected customers and providing support resources, while stating that it is not aware of any fraudulent use of the compromised personal information [3].